Bullboard - Stock Discussion Forum Longeveron Inc LGVN

Healthcare Biotechnology

Longeveron Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy... see more

Add To Watchlist

NDAQ:LGVN - Post Discussion

Longeveron Inc > Longeveron® Presents Lomecel-B(TM) Data for Alzhei

View:

Post by whytestocks on Oct 29, 2024 9:30pm

Longeveron® Presents Lomecel-B(TM) Data for Alzhei

NEWS: $LGVN Longeveron® Presents Lomecel-B(TM) Data for Alzheimer's Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24)Findings offer potential mechanistic and clinical insights in the development of cellular therapy Lomecel-B™ for mild Alzheimer’s disease (AD) Lomecel-B™ capacity to inhibit MMP14 correlates with improved clinical and biomarker outcomes in mild AD Immu...LGVN - Longeveron® Presents Lomecel-B(TM) Data for Alzheimer's Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24)